Zobrazeno 291 - 300
of 425
pro vyhledávání: '"Ted Cohen"'
Publikováno v:
Science translational medicine. 4(135)
The emergence of highly drug-resistant tuberculosis (TB) and interactions between TB and HIV epidemics pose serious challenges for TB control. Previous researchers have presented several hypotheses for why HIV-coinfected TB patients may suffer an inc
Autor:
Laura Pimpin, Helen R. Stagg, S. Bertel Squire, Ted Cohen, John M Watson, Punam Mangtani, Ibrahim Abubakar, Laura C. Rodrigues, Alimuddin Zumla
Publikováno v:
The Journal of infectious diseases. 205
Despite declining incidence in most high-income countries, tuberculosis shows no signs of disappearing in the near future. Although surveillance data from most Western European countries show relatively stable declines in the rate of tuberculosis ove
Publikováno v:
PLoS Medicine, Vol 9, Iss 11, p e1001347 (2012)
PLoS Medicine
PLoS Medicine
Nicolas Menzies and colleagues investigate the potential impact and cost-effectiveness of implementing Xpert MTB/RIF for diagnosing tuberculosis in five southern African countries.
Background The Xpert MTB/RIF test enables rapid detection of tub
Background The Xpert MTB/RIF test enables rapid detection of tub
Autor:
Frank van Leth, Nguyen Viet Nhung, Frank Cobelens, Svitlana Lyepshina, Bethany L. Hedt, Matteo Zignol, Saidi Egwaga, Ted Cohen, Wayne van Gemert
Publikováno v:
Epidemiology (Cambridge, Mass.), 23(2), 293-300. Lippincott Williams and Wilkins
In most high-incidence settings, the control of tuberculosis (TB) depends on diagnosis by microscopic examination of sputum, and treatment with standard combinations of antibiotics. Because drug resistant forms of TB are not identifiable by microscop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2f943e0cd85c00239fe96965505e6fa
https://pure.amc.nl/en/publications/multidrug-resistance-among-new-tuberculosis-cases-detecting-local-variation-through-lot-qualityassurance-sampling(a7531217-b84d-48c9-8ae8-573b5cf3d824).html
https://pure.amc.nl/en/publications/multidrug-resistance-among-new-tuberculosis-cases-detecting-local-variation-through-lot-qualityassurance-sampling(a7531217-b84d-48c9-8ae8-573b5cf3d824).html
Autor:
Ted Cohen, Michael J. Mina, Emily Griffiths, Victoriya V. Volkova, C. Jessica E. Metcalf, Bryan T. Grenfell, Silvie Huijben, Ruthie Birger, Roger D. Kouyos
Publikováno v:
Trends in Microbiology. 23:742
In the Review article ‘The potential impact of coinfection on antimicrobial chemotherapy and drug resistance’ by Birger et al., which was published in the September 2015 issue of Trends in Microbiology, the authors would like to update Michael Mi
Autor:
Ted Cohen, Reza Yaesoubi
Publikováno v:
European Journal of Operational Research.
We propose a class of mathematical models for the transmission of infectious diseases in large populations. This class of models, which generalizes the existing discrete-time Markov chain models of infectious diseases, is compatible with efficient dy
For pathogens that must be treated with combinations of antibiotics and acquire resistance through genetic mutation, knowledge of the order in which drug-resistance mutations occur may be important for determining treatment policies. Diagnostic speci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc524dc81099be85869e1c49a95ac9c9
https://europepmc.org/articles/PMC3219798/
https://europepmc.org/articles/PMC3219798/
Tuberculosis (TB) is a debilitating infectious disease that is responsible for ∼2 million deaths worldwide annually [1, 2]. Infection occurs through the transmission of respiratory droplets from individuals with TB; therefore persons in close and s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f14f9b3e2c82deca4b115b717ba02858
https://europepmc.org/articles/PMC3096792/
https://europepmc.org/articles/PMC3096792/
Publikováno v:
PLoS ONE
PLoS ONE, Vol 6, Iss 7, p e22927 (2011)
PLoS ONE, Vol 6, Iss 7, p e22927 (2011)
Background Quantifying isoniazid resistant (INH-R) tuberculosis (TB) is important because isoniazid resistance reduces the probability of treatment success, may facilitate the spread of multidrug resistance, and may reduce the effectiveness of isonia